MétaCan
Menu
Back to cohort
Record W4385269561 · doi:10.1136/thorax-2023-220262

Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials

2023· article· en· W4385269561 on OpenAlexafffund
Rohit Saha, Tài Pham, Pratik Sinha, Manoj V. Maddali, Giacomo Bellani, Eddy Fan, Charlotte Summers, Abdel Douiri, Gordon D. Rubenfeld, Carolyn S. Calfee, John G. Laffey, Daniel F. McAuley, Manu Shankar‐Hari

Bibliographic record

VenueThorax · 2023
Typearticle
Languageen
FieldMedicine
TopicRespiratory Support and Mechanisms
Canadian institutionsHealth Sciences CentreSunnybrook Health Science CentreUniversity of Toronto
FundersNational Heart, Lung, and Blood InstituteGenentechMedical Research CouncilEuropean Society of Intensive Care MedicineNational Institutes of HealthScience Foundation IrelandNational Institute of General Medical SciencesNational Institute for Health and Care ResearchGlaxoSmithKlineSt. Michael's Hospital FoundationUniversità degli Studi di Milano-BicoccaUniversità degli Studi di MilanoWellcome Trust
KeywordsMedicineAcute respiratory distressClinical trialIntensive care medicineRandomized controlled trialRespiratory distressFraction (chemistry)Internal medicineSurgeryLung

Abstract

fetched live from OpenAlex

Background Efficiency of randomised clinical trials of acute respiratory distress syndrome (ARDS) depends on the fraction of deaths attributable to ARDS (AFARDS) to which interventions are targeted. Estimates of AFARDSin subpopulations of ARDS could improve design of ARDS trials. Methods We performed a matched case-control study using the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE cohort. Primary outcome was intensive care unit mortality. We used nearest neighbour propensity score matching without replacement to match ARDS to non-ARDS populations. We derived two separate AFARDSestimates by matching patients with ARDS to patients with non-acute hypoxaemic respiratory failure (non-AHRF) and to patients with AHRF with unilateral infiltrates only (AHRF-UL). We also estimated AFARDSin subgroups based on severity of hypoxaemia, number of lung quadrants involved and hyperinflammatory versus hypoinflammatory phenotypes. Additionally, we derived AFAHRFestimates by matching patients with AHRF to non-AHRF controls, and AFAHRF-ULestimates by matching patients with AHRF-UL to non-AHRF controls. Results Estimated AFARDSwas 20.9% (95% CI 10.5% to 31.4%) when compared with AHRF-UL controls and 38.0% (95% CI 34.4% to 41.6%) compared with non-AHRF controls. Within subgroups, estimates for AFARDScompared with AHRF-UL controls were highest in patients with severe hypoxaemia (41.1% (95% CI 25.2% to 57.1%)), in those with four quadrant involvement on chest radiography (28.9% (95% CI 13.4% to 44.3%)) and in the hyperinflammatory subphenotype (26.8% (95% CI 6.9% to 46.7%)). Estimated AFAHRFwas 33.8% (95% CI 30.5% to 37.1%) compared with non-AHRF controls. Estimated AFAHRF-ULwas 21.3% (95% CI 312.8% to 29.7%) compared with non-AHRF controls. Conclusions Overall AFARDSmean values were between 20.9% and 38.0%, with higher AFARDSseen with severe hypoxaemia, four quadrant involvement on chest radiography and hyperinflammatory ARDS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.517
metaresearch head score (Gemma)0.752
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.517
Threshold uncertainty score0.596

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.5170.752
Meta-epidemiology (narrow)0.0040.002
Meta-epidemiology (broad)0.0120.012
Bibliometrics0.0070.006
Science and technology studies0.0010.005
Scholarly communication0.0070.008
Open science0.0050.006
Research integrity0.0070.007
Insufficient payload (model declined to judge)0.0110.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.168
GPT teacher head0.466
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueThoraxSame topicRespiratory Support and MechanismsFrench-language works237,207